For this reason, we hypothesised that targeting the JAK/STAT signaling pathway might be more effective than targeting one cytokine alone, such as with the use of anti-VEGF antibodies, particularly in the context of diabetes mediated BRB breakdown. Here, SOAT1 is linked to diabetes mellitus.